The FDA has officially approved its diabetes drug Lilly’s Mounjaro to prevent a heart attack or stroke in adults with type 2 diabetes who are at high risk of cardiovascular events on Friday. Mounjaro is the primary drug that targets the GLP-1 protein and is also used for weight loss. .. .
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan